News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
90,603 Results
Type
Article (6639)
Company Profile (41)
Press Release (83923)
Section
Business (27678)
Career Advice (125)
Deals (3982)
Drug Delivery (30)
Drug Development (14080)
Employer Resources (12)
FDA (2826)
Job Trends (2107)
News (49105)
Policy (5987)
Tag
Academia (421)
Allergies (21)
Alliances (8927)
Alzheimer's disease (235)
Antibody-drug conjugate (ADC) (24)
Approvals (2810)
Artificial intelligence (21)
Bankruptcy (18)
Best Places to Work (1778)
BIOSECURE Act (15)
Biosimilars (52)
Biotechnology (29)
Breast cancer (22)
Cancer (227)
Career advice (108)
Cell therapy (48)
Clinical research (11149)
Collaboration (87)
Compensation (17)
COVID-19 (529)
C-suite (25)
Data (227)
Diabetes (20)
Diagnostics (507)
Drug pricing (15)
Earnings (9209)
Events (11485)
Executive appointments (45)
FDA (2977)
Funding (63)
Gene therapy (52)
GLP-1 (96)
Government (1287)
Healthcare (1934)
Immunology and inflammation (19)
Infectious disease (547)
Inflammatory bowel disease (40)
IPO (1818)
Job creations (385)
Job search strategy (106)
Layoffs (48)
Legal (553)
Lung cancer (53)
Manufacturing (69)
Medical device (1158)
Medtech (1159)
Mergers & acquisitions (2207)
Metabolic disorders (45)
Neuroscience (280)
NextGen Class of 2024 (696)
Non-profit (346)
Northern California (280)
Obesity (16)
Opinion (39)
Patents (14)
Peanut (18)
People (7816)
Phase I (3657)
Phase II (4650)
Phase III (4078)
Pipeline (133)
Policy (27)
Postmarket research (293)
Preclinical (1437)
Press Release (66)
Radiopharmaceuticals (34)
Rare diseases (37)
Real estate (912)
Regulatory (4554)
Research institute (386)
Southern California (290)
Startups (572)
United States (2485)
Vaccines (140)
Date
Today (29)
Last 7 days (188)
Last 30 days (707)
Last 365 days (6573)
2024 (6008)
2023 (6959)
2022 (9056)
2021 (9473)
2020 (8172)
2019 (5837)
2018 (4510)
2017 (5058)
2016 (4617)
2015 (5269)
2014 (3717)
2013 (2892)
2012 (2985)
2011 (3146)
2010 (2572)
Location
Africa (91)
Asia (7314)
Australia (865)
California (652)
Canada (156)
China (91)
Colorado (23)
Delaware (16)
Europe (13539)
Florida (71)
Georgia (13)
Illinois (30)
Indiana (25)
Maryland (230)
Massachusetts (432)
Minnesota (36)
New Jersey (279)
New York (180)
North Carolina (148)
Northern California (280)
Ohio (28)
Pennsylvania (119)
South America (134)
Southern California (290)
Texas (74)
Washington State (53)
90,603 Results for "gensight biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
GenSight Biologics Renegotiates Financial Obligations and Provides Operational Updates
GenSight Biologics announced the renegotiation of certain financial obligations, securing its financial position and improving short-term flexibility.
June 20, 2024
·
6 min read
Business
GenSight Biologics Appoints William Monteith to its Board of Directors
GenSight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, announced the appointment of William Monteith to its Board of Directors.
June 3, 2024
·
4 min read
Policy
GenSight Biologics Announces its 2024 Financial Calendar
GenSight Biologics today announced its financial calendar for 2024.
April 4, 2024
·
1 min read
Press Releases
GenSight Biologics Announces LUMEVOQ® Scientific Updates at AAO 2024
October 17, 2024
·
4 min read
Press Releases
GenSight Biologics Announces Submission of LUMEVOQ® Dossier to ANSM to Prepare for Restart of Early Access Program in France
November 13, 2024
·
4 min read
GenSight Biologics to Present at Upcoming Medical Conferences and Stakeholder Meetings - June 04, 2024
GenSight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, announced its participation at key medical and stakeholder meetings in the remainder of 2024.
June 4, 2024
·
3 min read
GenSight Biologics: Annual General Meeting on May 29, 2024
GenSight Biologics announced that it will hold its Annual General Meeting on May 29, 2024, at 9:00 am CEST at the Company’s headquarters, 74 rue du Faubourg Saint-Antoine, 75012 Paris, France.
May 7, 2024
·
2 min read
Business
GenSight Biologics Reports Cash Position as of September 30, 2024, and Provides Business Update
October 24, 2024
·
5 min read
Policy
GenSight Biologics Announces the Filing of its 2023 Universal Registration Document
GenSight Biologics today announced the filing of its 2023 Universal Registration Document (URD) in English with the French market authority (Autorités des Marchés Financiers , or AMF) under the reference D.24-0299.
April 18, 2024
·
1 min read
Press Releases
GenSight Biologics Announces Publication of Meta-Analyses Showing Better Outcomes for ND4-LHON Patients Treated with LUMEVOQ®
October 28, 2024
·
5 min read
1 of 9,061
Next
